Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NewMed Energy LPDKDRF 74 EV-to-EBITDA is 10.72 as of Aug. 19, 2026, which is 29% above its 10-year median of 8.32. GuruFocus rates DKDRF with a GF Score™ of 74/100 and a GF Value™ of $3.51 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 770 Oil & Gas companies, NewMed Energy LP ranks worse than 69.61% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, NewMed Energy LP's enterprise value is $7,896.9 Mil.
NewMed Energy LP's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 was $736.4 Mil. Therefore, NewMed Energy LP's EV-to-EBITDA for today is 10.72.
The historical rank and industry rank for NewMed Energy LP's EV-to-EBITDA or its related term are showing as below:
DKDRF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.92 Med: 8.32 Max: 73.98
Current: 10.69
During the past 13 years, the highest EV-to-EBITDA of NewMed Energy LP was 73.98. The lowest was 4.92. And the median was 8.32.
DKDRF's EV-to-EBITDA is ranked worse than 69.61% of 770
companies
in the Oil & Gas industry
Industry Median: 7.575
vs DKDRF: 10.69
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
NewMed Energy LP (OTCPK:DKDRF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
NewMed Energy LP's PE Ratio (TTM) for today is calculated as:
NewMed Energy LP's share price for today is $5.20.
NewMed Energy LP's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.223.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for NewMed Energy LP's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Oil & Gas E&P subindustry, NewMed Energy LP's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NewMed Energy LP EV-to-EBITDA vs Oil & Gas Industry
For the Oil & Gas industry and Energy sector, NewMed Energy LP's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where NewMed Energy LP's EV-to-EBITDA falls into.
NewMed Energy LP's current Enterprise Value is $7,896.9 Mil.
NewMed Energy LP's EBITDA for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $736.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NewMed Energy LP (DKDRF) has a EV-to-EBITDA of 10.72 as of Aug. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NewMed Energy LP. This is 29% above median its historical median of 8.32. Over the past decade, NewMed Energy LP's EV-to-EBITDA has ranged from 4.92 to 73.98. According to the industry distribution chart, NewMed Energy LP ranks #536 out of 770 companies in the Oil & Gas industry, placing it in the top 69.6%.
Is NewMed Energy LP's EV-to-EBITDA too high?
NewMed Energy LP's current EV-to-EBITDA of 10.72 is 29% above median its 10-year median of 8.32. Over the past 10 years, this metric has ranged from a low of 4.92 to a high of 73.98. The Oil & Gas industry median EV-to-EBITDA is 7.58. NewMed Energy LP's value of 10.72 is 41.5% above this industry median. Based on the distribution chart, NewMed Energy LP ranks #536 out of 770 companies in the Oil & Gas industry, which is below the industry midpoint. Overall, NewMed Energy LP has a GF Score™ of 74/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NewMed Energy LP's EV-to-EBITDA compare to COP and EOG?
According to the Oil & Gas industry distribution chart, NewMed Energy LP ranks #536 out of 770 companies for EV-to-EBITDA. This places NewMed Energy LP in the lower half of its industry. The industry median EV-to-EBITDA is 7.58. NewMed Energy LP's value of 10.72 is 41.5% above this benchmark. Historically, NewMed Energy LP's own EV-to-EBITDA has ranged from 4.92 to 73.98 over the past decade. While the company's 10-year median is 8.32 vs. the industry median of 7.58, NewMed Energy LP has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for an Oil & Gas company?
The median EV-to-EBITDA among Oil & Gas companies is 7.58, based on 770 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NewMed Energy LP's current EV-to-EBITDA of 10.72 is 41.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on NewMed Energy LP. For the Oil & Gas industry, the median EV-to-EBITDA is 7.58 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NewMed Energy LP's current EV-to-EBITDA is 10.72, which is 29% above median its own 10-year median of 8.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NewMed Energy LP stock overvalued right now?
Based on GuruFocus' analysis, NewMed Energy LP (DKDRF) is currently considered Significantly Overvalued. The stock's GF Value™ is $3.51, compared to a current price of $5.20 — trading 48.1% above its estimated fair value. The current EV-to-EBITDA is 10.72, which is 29% above median its 10-year median of 8.32 and 41.5% above the Oil & Gas industry median of 7.58. NewMed Energy LP's overall GF Score™ is 74/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For NewMed Energy LP (DKDRF), the current EV-to-EBITDA is 10.72 as of Aug. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is NewMed Energy LP (DKDRF) Overvalued in 2026?
Based on GuruFocus' analysis, NewMed Energy LP stock appears to be overvalued.
The current stock price of $5.20 is trading 48.1% above its estimated GF Value™ of $3.51.
GuruFocus considers NewMed Energy LP to be Significantly Overvalued.
Key valuation signals for DKDRF:
EV-to-EBITDA: 10.72 (29% above median its 10-year median of 8.32)
GF Value™: $3.51 vs. price of $5.20 (48.1% above fair value)
Industry Position: 41.5% above the Oil & Gas median (#536 of 770)
No single metric tells the full story. See the DKDRF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
NewMed Energy LP operates in the energy field. Its primary business is exploring, developing, producing, and marketing natural gas, condensate, and oil in Israel and Cyprus and promoting various natural gas-based projects. The Partnership aims to increase the volume of its natural gas sales.
74GF Score
Get the complete analysis for DKDRF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DKDRF has been successfully added to your 
